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Abstract The chemoattractant cAMP induces directed cell 
locomotion in Dictyostelium cells. Several second messenger 
pathways are activated upon binding of cAMP to G-protein-
coupled receptors, including adenylyl cyclase, guanylyl cyclase, 
phospholipase C, and the opening of plasma membrane Ca2+ 
channels. These second messenger responses are unaltered in 
many chemotactic mutants, except for the cGMP response. 
Activation of guanylyl cyclase depends on G-proteins and is 
regulated by a cGMP-binding protein in a complex manner. This 
cGMP-binding protein also mediates intracellular functions of 
cGMP to activate a PKC-related kinase that phosphorylates 
myosin II heavy chain, thereby allowing myosin filaments to 
rearrange during cell movement. 
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1. Dictyostelium development and chemotaxis 
Dictyostelium is a fungus with distinct evolutionary traits. 
Comparisons of protein sequences suggests that it diverted 
about half-way between yeast and the splitting between ani-
mals and plants [1]. The amoeboid cells live in the soil where 
they feed on bacteria. Growing cells are chemotactically sen-
sitive towards several compounds including folic acid and 
pterin, which are secreted by their prey [2]. When the bacteria 
become scarce, starvation induces the expression of a cAMP 
sensory system: some cells start to secrete cAMP to which 
cells in the surrounding respond with a chemotactic reaction. 
A cell aggregate is formed that can be composed of up to 
100000 cells. cAMP continues to be secreted by the cells in-
ducing cell differentiation by complex mechanisms that are 
beginning to be understood [3-5]. Finally, a fruiting body is 
formed composed of highly vacuolized cells arranged in a 
stalk with on top spores embedded in a slime droplet. These 
spores are relatively safe to environmental stress; they resist 
extreme temperatures, humidity and pH, and they can pass 
the digestive track of birds and nematodes [6]. 
For chemotaxis at least two components are required: 
movement and orientation. Bacteria move by a combination 
of smooth swimming and tumbling. After a tumble, cells swim 
in a new random direction. Bacteria move in the direction of a 
chemotactic gradient, because tumbling is suppressed when an 
temporal increase of the chemoattractant is detected [7]. Thus, 
bacteria do not measure the special gradient, and they must 
move in order to read the gradient. In contrast, immobile 
Dictyostelium cells are still able to extend pseudopods in the 
direction of a cAMP gradient, as was shown using electro-
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poreted cells in Ca2+-buffered solutions [8]. Other experiments 
[9] suggest that cells do not show chemotaxis when placed in a 
steep spatial gradient of which the concentration is every-
where decreasing with time. It thus appears that cells use 
both spatial and temporal clues to orient in a cAMP chemo-
tactic gradient. Detection of temporal clues is imposed by the 
biochemistry of guanylyl cyclase activation, which shows rap-
id and exact adaptation to constant stimuli (see below). 
Directionality of movement is likely to be mediated by a 
differential occupancy of chemoattractant receptors between 
the front and back of the cell. Chemotaxis towards cAMP is 
very efficient: cells move at very low cAMP concentrations in 
shallow gradients with a 2% difference between the ends of a 
cell. It has been calculated that at threshold chemotactic re-
sponses only 400 surface cAMP receptors are occupied, about 
5 more at the front than at the back of the cell (see [10]). 
Clearly, evolution has driven the mechanism of Dictyostelium 
chemotaxis to perform at the verge of stochastic and thermal 
fluctuations. 
2. Chemoattractant receptors and G-proteins 
Folic acid, pterin and cAMP are detected by surface recep-
tors that interact with G-protein (see [11]). Four genes encod-
ing the cAMP receptor have been identified, those for folic 
acid and pterin are unknown. The cAMP receptors are pre-
dicted to pass the membrane seven times, typical for receptors 
that interact with G-proteins. In the Dictyostelium genome, 
eight genes encoding Gee and one G|3 subunits have been 
identified [12,13]. Cells with a deletion of Gf$ can not chemo-
tax to any chemoattractant. Deletion of Ga-subunits demon-
strate that Goe4 interacts with folic acid and pterin receptors 
[14], while Gcc2 is essential for cAMP chemotaxis [15,16]. 
3. Chemotactic mutants 
Although chemoattractants such as cAMP, folic acid and 
pterin are detected by different surface receptors and G-pro-
teins, it is expected that somewhere in the transduction cas-
cade to directed cell locomotion the signals merge into one 
pathway. It has been suggested that the same pool of guanylyl 
cyclase is activated by both cAMP and folic acid, because cells 
that are simultaneously sensitive to both chemoattractants do 
not show additivity of the cGMP response [17]. Based on 
these observations a screen for hunting chemotaxis mutants 
was devised. From about 10000 mutagenized cells, 51 mu-
tants were identified that do not chemotax to cAMP, 21 mu-
tant do not chemotax to folic acid, and 10 mutants do not 
respond to either chemoattractant. These mutants, designated 
KI1-KI10, were investigated genetically and biochemically in 
detail [18]. One mutant (KI-3) appears to be the only false 
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Fig. 1. Model of signal transduction of chemoattractants and osmotic stress via cGMP in Dictyostelium. Folic acid (FA) and cAMP bind to 
different surface receptors that interact with different G-proteins. These signals meet before guanylyl cyclase (GCase) producing the second mes-
senger cGMP, that interacts with a cGMP-binding protein (cGBP) or is degraded by a cGMP-specific phosphodiesterase. This binding protein 
indirectly induces the phosphorylation of myosin II heavy chain (MYO); it also regulates guanylyl cyclase in a complex manner (not shown; 
see [33]). Guanylyl cyclase is also activated by osmotic stress via an unknown pathway that does not include cAMP receptors or G-proteins. 
The defect of KI and stmF mutants are discussed in the text. Besides guanylyl cyclase, chemoattractants activate several other second messenger 
pathways that are probably not involved in chemotaxis. 
positive, all other mutant are severely defective, indicating the 
powerful selection method. Genetic analysis revealed that all 
mutants are recessive except KI-10. Interestingly this domi-
nant mutant does not show chemotaxis to cAMP, folic acid 
and pterin, but responds normal to bacteria, yeast extract and 
human urine; this must mean that these complex mixtures 
contain still other unidentified chemoattractants. Further ge-
netic analysis demonstrates that all mutants can complement 
each other [18]. Cloning the mutated genes should establish 
whether each complementation group belongs to a different 
gene. 
Biochemical analysis demonstrate the normal activation of 
adenylyl cyclase and phospholipase C in the non-chemotaxis 
KI mutants, suggesting that these enzymes may not mediate 
chemotaxis [18]. This confirms the reversed experiments with 
mutants deleted in the genes encoding adenylyl cyclase [19] or 
phospholipase C [20] which show normal chemotaxis. KI mu-
tants are severely defective in the activation of guanylyl cy-
clase or the detection of intracellular cGMP, suggesting that 
cGMP plays an essential role in mediating chemotaxis [18]. 
4. cGMP response in vivo 
Chemoattractants induce a ten-fold increase of the intra-
cellular cGMP concentration; maximal levels are obtained 
after 10 s and basal levels are recovered within 30 s. cGMP 
levels start to rise after addition of cAMP with a lag-time of 
only 0.8 s, indicating that binding of cAMP to the receptor, 
and activation of the receptor, G-protein and guanylyl cyclase 
is completed within 1 s [21]. The cGMP response is controlled 
by an adaptation mechanism: when cells are restimulated at 
30 s, they only respond to the second stimulus if its concen-
tration is higher than that of the first stimulus. Adaptation is 
very fast with half-maximal adaptation after 2.5 s and com-
plete adaptation after 10 s. When the second stimulus is ap-
plied later than 30 s, cells slowly regain responsiveness: de-
adaptation shows first order kinetics with a half-time of about 
90 s [22]. Both folic acid and cAMP induce similar cGMP 
responses; however, the responses are not additive, and cells 
stimulated with folic acid are adapted to folic acid, but not to 
cAMP and visa versa [23]. These observations suggest that 
folic acid and cAMP share the same pool of guanylyl cyclase, 
and that adaptation is localized in the unshared part of the 
transduction pathway, between receptors and guanylyl cy-
clase. 
The kinetics of the cGMP response is extremely robust. 
Most drugs or mutations that interfere with signal transduc-
tion alter the magnitude of the cGMP response, but not the 
timing. There are two exceptions, mutant stmF and mutants 
KI-2 and KI-7. The cGMP response in stmF is both enhanced 
and prolonged, due to a mutation in the structural gene of a 
specific cGMP phosphodiesterase [24-26]. In wild-type cells 
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the enzyme is activated about 3-fold by cGMP. Detailed non-
equilibrium kinetics suggests that in vivo this activation is 
mainly responsible for the rapid reduction of cGMP levels 
after 10 s [27,28]. Although mutants KI-2 and 7 also show a 
delayed cGMP response, cGMP phosphodiesterase activity is 
normal [18]. These mutants appear to be defective in the in-
hibition of guanylyl cyclase by a cGMP-binding protein (see 
below), resulting in prolonged guanylyl cyclase activity. 
5. Regulation of guanylyl cyclase 
Dictyostelium guanylyl cyclase is strongly inhibited by Ca2+ 
ions; inhibition is cooperative with a Hill coefficient of 2.3; 
half-maximal inhibition occurs at about 50 nM Ca2+ [29]. 
Experiments with permeabilized cells and computer simula-
tions suggest that Ca2+ regulates the magnitude of the 
cGMP response, not its timing [28]. The inhibition of Dictyo-
stelium guanylyl cyclase activity by Ca2+ is similar to the 
regulation of this enzyme in the vertebrate eye [30]. 
Mutant KI-8 has a strongly reduced guanylyl cyclase activ-
ity. Mutant KI-10 has normal basal guanylyl cyclase activity 
which, however, can not be stimulated by cAMP or folic acid. 
Mutants KI-2 and KI-7 show a delayed cGMP response with 
a maximum at 20 s after stimulation versus 10 s in wild-type 
cells. Mutants KI-4, 5, 6, and 9 do show a cAMP-mediated 
cGMP response, but only at elevated stimulus concentrations 
[18]. 
In cell lysates Mg2+-dependent guanylyl cyclase activity is 
membrane bound, but requires a protein from the cytosol to 
show full activity [31]. Furthermore, guanylyl cyclase activity 
is strongly reduced at conditions where protein kinase activity 
is high [32]. Recent observations [33] show that the cytosolic 
factor is absent or non-functional in mutants KI-4 and KI-5, 
whereas inhibition of guanylyl cyclase activity by phospho-
rylation reactions is no longer detected in mutants KI-2 and 
KI-7. These mutants have a defect in a cytosolic cGMP-bind-
ing protein [34]. Thus, we have proposed that this cGMP-
binding protein is a kinase that regulates guanylyl cyclase 
activity [33]. 
6. Function of intracellular cGMP 
The intracellular protein that binds cGMP has been char-
acterized to some extend. This protein is unaltered in stm¥ 
mutants, demonstrating that it is not (part of) a cGMP-phos-
phodiesterase [25], but most likely a cGMP-dependent protein 
kinase [35]. Kinetic studies of cGMP-binding to the protein 
reveal two binding forms: cGMP may dissociate fast (F-form) 
or slow (S-form). Oligonucleotides promote the S-form [36]. 
In KI-4/5 mutants the cGMP-binding sites are locked in the S-
form whereas in KI-2/7 only the F-form can be detected; 
oligonucleotides have no effect on cGMP-binding in these 
mutants [34]. It is not clear whether these mutants are defec-
tive in the structural gene of the cGMP-binding protein/kin-
ase. 
Several experiments suggest a connection between cGMP 
and myosin heavy chain phosphorylation [37,38] by a PKC 
homolog that is activated indirectly by cGMP [39]. cGMP 
also plays a role in regulating the phosphorylation of myosin 
light chain [40]. Phosphorylation of myosin heavy and light 
chains is promoted in mutant stmF with no cGMP phospho-
diesterase, whereas it is absent in mutants KI-10 and KI-8 
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with no cGMP response, or in mutant KI-4 with an altered 
intracellular cGMP-binding protein ([38,40], Kuwayama and 
Van Haastert, unpublished observations). It is unlikely that 
phosphorylation of myosin is the only target of intracellular 
cGMP. Cells in which the myosin heavy chain is deleted dis-
play nearly normal chemotaxis [41], whereas mutants defective 
in cGMP synthesis show no chemotaxis. 
7. cGMP and osmo-regulation 
Cells have two main strategies to cope with hyper-osmotic 
stress: using a wall to provide resistance against the turgor 
pressure, or adjusting the intracellular osmotic value to that of 
the outside. Dictyostelium has still another strategy, which is 
to rearrange actin and myosin filaments under the cortex. This 
may provide physical resistance to osmotic stress. Intracellular 
cGMP plays an essential role in this process. 
In wild-type cells, osmotic stress induces the synthesis of 
large amounts of cGMP [42], which in turn leads to myosin 
phosphorylation and redistribution of myosin filaments [43]. 
Cells lacking myosin heavy chain or guanylyl cyclase are more 
sensitive to osmotic stress than wild-type cells. Mutant cells 
are also osmo-sensitive when myosin can not be phospho-
rylated, either by mutating the phosphorylated threonines to 
alaninies [43], or in mutants KI-4 and KI-5 where the intra-
cellular rise in cGMP can not be transmitted to the myosin 
kinase. On the other hand, chemotaxis mutants carl~lcar3~, 
gp~ and KI-10 with mutation upstream of guanylyl cyclase 
are osmo-resistant and show a good osmo-induced cGMP 
response, suggesting that the osmo-resistance and chemotaxis 
pathway use different detectors, but share the cGMP machi-
nery (Fig. 1; Kuwayama and Van Haastert, unpublished ob-
servations). 
8. Conclusions 
Mutant analysis clearly demonstrate that the second mes-
senger cGMP plays a pronounced role in chemotaxis. Intra-
cellular cAMP may not be important at all, whereas the func-
tion of PLC-derived second messengers (Ins(l,4,5)P3, DAG 
and Ca2+) is not clear. Identification of the genes encoding 
proteins producing, degrading or detecting cGMP should al-
low to unravel the early steps in the transduction of chemo-
tactic signals from receptor to second messengers. This should 
then be connected with the wealth of information on the reg-
ulation of the locomotion apparatus that is rapidly emerging. 
Indeed, Dictyostelium may be the first eukaryotic system 
where chemotaxis is understood at a molecular level. 
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